https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

IDIVAL reaccredited by the Carlos III Health Institute

29 de June de 2020

IDIVAL obtains the official reaccreditation of the Carlos III Health Institute (ISCIII) as a Health Research Institute. A fundamental certification for the exercise of its competences in such fundamental areas as organ and tissue transplants or new therapies, neuroscience, cancer, infectious diseases and the immune system or diseases related to aging and life habits, in […]

Read more →

Biobanco Valdecilla participates in a digital meeting

22 de June de 2020

The Biodeco Valdecilla participates in the first digital meeting of the NorayBanks Community “Pandemics: challenges and opportunities for biobanks” with Biobanco HCB-IDIBAPS. The situation caused by COVID-19 has forced biobanks and their technology partners to take change measures on a daily basis, to establish new forms of work, applicable to any type of biobank and […]

Read more →

Two IDIVAL projects financed in the Call for Challenges-Collaboration

18 de June de 2020

IDIVAL obtains financing for two of the three projects presented in the Call for Challenges – Collaboration according to the proposal for a provisional resolution to grant aid to the call for early processing of 2019 for R + D + i projects “Challenges – Collaboration” of the Program State Research, Development and Innovation Oriented […]

Read more →

BBVA Foundation Frontiers of Knowledge Awards

11 de June de 2020

The BBVA Foundation Frontiers of Knowledge Awards are developed in collaboration with the Higher Council for Scientific Research (CSIC) and recognize fundamental contributions in a wide range of fields of scientific knowledge, technology, humanities and artistic creation. The disciplines and domains of the Frontiers of Knowledge Awards are as follows: 1. Basic Sciences (Physics, Chemistry, […]

Read more →

Effectiveness efficacy and safety of antipsychotics

The PAFIP group (Initial Psychosis Care Program) that is part of the IDIVAL Psychiatry group has published in the International Journal of Neuropsychopharmacology the article “Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone” in which six of the most widely used antipsychotics […]

Read more →

22nd national call for research projects Nursing Valdecilla

9 de June de 2020

Open the 22nd National Call for Research Projects “Enfermería Valdecilla” organized by the Research Institute Marqués de Valdecilla (IDIVAL) in collaboration with the Directorate of Nursing of the Hospital Universitario “Marqués de Valdecilla” and “Fundación Caja Cantabria”. The objective of this call is to promote the participation of Nursing Professionals in the elaboration and development […]

Read more →

Relaxation technique could improve anxiety levels in cancer patients

The article “Cancer Patients and Anxiety: A Gender Perspective” published in the “International Journal of Environmental Research and Public Health” is part of a study that received first prize in the 16th edition of the National Nursing Prize of the Hospital Universitario Marqués de Valdecilla with the title “Progressive muscle relaxation technique in the care […]

Read more →

Cris Calls Against Cancer

1) CRIS Excellence Program It supports researchers with outstanding careers, allows their consolidation as a group of Excellence, and facilitates the development of translational research projects with the potential to transform the current landscape of cancer treatment. Maximum financial endowment of € 1,250,000 distributed over 5 years. The beneficiaries of this program can be: Researchers […]

Read more →

Valdecilla Biobank collects a total of 2500 samples COVID-19

3 de June de 2020

On April 14, the National Network of Biobanks (RNBB) began incorporating human biological samples from patients with COVID-19 disease into biobanks to make them available to research projects. In just 5 weeks, it has registered nearly 62,000 samples, mainly serum, nasopharyngeal exudates, blood, plasma and leukocytes, as well as urine, faeces, nucleic acids or tissues, […]

Read more →

Reintegration of IDIVAL researchers

24 de May de 2020

In order to carry out the reinstatement of the researchers to their jobs, IDIVAL has held meetings with the researchers and with the Health and Safety Committee to initiate the de-escalation of some of its workers. In order to carry out a safe reinstatement of workers, general de-escalation rules have been developed, a general procedure […]

Read more →